Skip to Content

SEC Filings

Filing date	Form	Description	View
May 15, 2012	8-K	Report of unscheduled material events or corporate event	0001104659-12-037122.pdf 0001104659-12-037122.rtf 0001104659-12-037122.xls View HTML
May 15, 2012	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001104659-12-037267.pdf 0001104659-12-037267.rtf 0001104659-12-037267.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Jun 14, 2012	4	Statement of changes in beneficial ownership of securities	0001179110-12-010199.pdf 0001179110-12-010199.rtf View HTML
Jun 18, 2012	8-K	Report of unscheduled material events or corporate event	0001104659-12-044129.pdf 0001104659-12-044129.rtf 0001104659-12-044129.xls View HTML
Jun 19, 2012	3	Initial filing by director officer or owner of more than ten percent.	0001179110-12-010504.pdf 0001179110-12-010504.rtf View HTML
Jun 19, 2012	4	Statement of changes in beneficial ownership of securities	0001179110-12-010507.pdf 0001179110-12-010507.rtf View HTML
Jul 05, 2012	4	Statement of changes in beneficial ownership of securities	0001179110-12-011207.pdf 0001179110-12-011207.rtf View HTML
Jul 13, 2012	8-K	Report of unscheduled material events or corporate event	0001104659-12-048921.pdf 0001104659-12-048921.rtf 0001104659-12-048921.xls View HTML
Jul 17, 2012	3	Initial filing by director officer or owner of more than ten percent.	0001179110-12-011582.pdf 0001179110-12-011582.rtf View HTML
Jul 17, 2012	4	Statement of changes in beneficial ownership of securities	0001179110-12-011588.pdf 0001179110-12-011588.rtf View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2024 Merrimack Pharmaceuticals.